Non-covalent BTK inhibitor found effective in some heavily pretreated patients with CLL.
Increased Risk of Stroke, Bleeding and Atrial Fibrillation in Older CLL Patients Treated with Ibrutinib
A new study found older adults with CLL have increased risk of adverse events such as atrial fibrillation.
Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma
Relapsed/refractory mantle cell lymphoma patients significantly benefited from CAR T-cell therapy, with durable complete responses and manageable adverse events, according to new findings from the ZUMA-2 trial.